Cargando…

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials

Missing data are a frequent problem in cost-effectiveness analysis (CEA) within a randomised controlled trial. Inappropriate methods to handle missing data can lead to misleading results and ultimately can affect the decision of whether an intervention is good value for money. This article provides...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faria, Rita, Gomes, Manuel, Epstein, David, White, Ian R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Practical Application
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244574/ https://www.ncbi.nlm.nih.gov/pubmed/25069632 http://dx.doi.org/10.1007/s40273-014-0193-3

Ejemplares similares

Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
por: Leurent, Baptiste, et al.
Publicado: (2018)

Strategies for handling missing data in randomised trials
por: White, Ian R
Publicado: (2011)

A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper
por: Seo, Mikyung Kelly, et al.
Publicado: (2021)

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

Conducting Qualitative Research Online: Challenges and Solutions
por: Carter, Stacy M., et al.
Publicado: (2021)

Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy
por: Drake, Tom L., et al.
Publicado: (2017)

The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework
por: Vallejo-Torres, Laura
Publicado: (2023)

Conducting Trial-Based Economic Evaluations Using R: A Tutorial
por: Ben, Ângela Jornada, et al.
Publicado: (2023)

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
por: Sendi, Pedram
Publicado: (2020)

Canonical Causal Diagrams to Guide the Treatment of Missing Data in Epidemiologic Studies
por: Moreno-Betancur, Margarita, et al.
Publicado: (2018)

Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method
por: Landfeldt, Erik, et al.
Publicado: (2018)

Common Methods for Handling Missing Data in Marginal Structural Models: What Works and Why
por: Leyrat, Clémence, et al.
Publicado: (2020)

Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations
por: Shen, Jing, et al.
Publicado: (2018)

Economic Evaluation of Digital Health Interventions: Methodological Issues and Recommendations for Practice
por: Gomes, Manuel, et al.
Publicado: (2022)

Extensions of Health Economic Evaluations in R for Microsoft Excel Users: A Tutorial for Incorporating Heterogeneity and Conducting Value of Information Analyses
por: Naylor, Nichola R., et al.
Publicado: (2022)

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
por: Verguet, Stéphane, et al.
Publicado: (2016)

The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice
por: Wouterse, Bram, et al.
Publicado: (2023)

Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency
por: Shields, Gemma E., et al.
Publicado: (2021)

Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities
por: Keeney, Edna, et al.
Publicado: (2018)

Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan
por: Treish, Imad, et al.
Publicado: (2021)

Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom
por: Whitehurst, David G. T., et al.
Publicado: (2018)

Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations
por: Gabrio, Andrea, et al.
Publicado: (2017)

Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide
por: de Bekker-Grob, Esther W., et al.
Publicado: (2015)

Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation
por: Dixon, Padraig, et al.
Publicado: (2016)

One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit
por: McCabe, Christopher, et al.
Publicado: (2019)

Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches
por: Elbasha, Elamin H.
Publicado: (2022)

Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon
por: Dahham, Jalal, et al.
Publicado: (2022)

A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R
por: Lin, Yi-Shu, et al.
Publicado: (2023)

Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance
por: Williams, Jake T. W., et al.
Publicado: (2022)

An Alternative Approach to Decomposing the Redistributive Effect of Health Financing Between and Within Groups Using the Gini Index: The Case of Out-of-Pocket Payments in Nigeria
por: Ataguba, John E., et al.
Publicado: (2019)

Comparing methods for handling missing cost and quality of life data in the Early Endovenous Ablation in Venous Ulceration trial
por: Diop, Modou, et al.
Publicado: (2022)

Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers
por: Walker, Simon, et al.
Publicado: (2019)

How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England
por: Clarke, Caroline S., et al.
Publicado: (2021)

Erratum to: Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations
por: Gabrio, Andrea, et al.
Publicado: (2017)

So You Want to Build Your Disease’s First Online Patient Registry: An Educational Guide for Patient Organizations Based on US and European Experience
por: Wicks, Paul, et al.
Publicado: (2023)

How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts
por: Franklin, Matthew, et al.
Publicado: (2023)

Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment
por: Kent, Seamus, et al.
Publicado: (2020)

Time for Tele-TTO? Lessons Learned From Digital Interviewer-Assisted Time Trade-Off Data Collection
por: Lipman, Stefan A.
Publicado: (2020)

The prevention and handling of the missing data
por: Kang, Hyun
Publicado: (2013)

Reporting, handling and assessing the risk of bias associated with missing participant data in systematic reviews: a methodological survey
por: Akl, Elie A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mq465bfhskjsr2hpil8q5l8mfp